Back to top
This division currently comprises N4 Pharma’s Nuvec® vaccine delivery technology and its single dose hepatitis B vaccine. N4 Pharma is undertaking research to demonstrate that its delivery systems can protect the vaccine in the body and improve the ability of the vaccine to produce an immune response.

It is working with outsourced experts to develop commercially relevant results which would allow it to engage with suitable partners. These partners would then pay N4 Pharma a license fee to use its delivery system as part of the partners’ own vaccine development programme. N4 Pharma is continuing its research programme to demonstrate functionality, transfection efficiency and toxicology of its technology.

Vaccines Pipeline

Vaccines in the pipeline



Single dose Hepatitis B